Form 4 for MIST Milestone Pharmaceuticals Inc.
Accepted 2022-09-09 00:00:00 ET · period of report 2022-09-07 · accession 0000902664-22-004219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-09-09 | 2022-09-07 | MIST | RTW INVESTMENTS, LP | 10% | P - Purchase | $8.71 | +1.56M | 4.32M | +56% | +$13.56M |
| I | 2022-09-09 | 2022-09-07 | MIST | RTW INVESTMENTS, LP | 10% | S - Sale | $8.71 | -1.56M | 4.32M | -27% | -$13.56M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, no par value ("Common Shares") | 2022-09-07 | P | A | 1,557,346 | $8.71 | 4,315,102 | I See footnote | — | — | (F1) Ordinary course rebalancing transactions in which certain RTW Funds (as defined below) rebalance holdings of the Issuer among the RTW Funds. After the transactions reported herein, the amount of Common Shares of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change. (F2) This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to Common Shares held by certain investment funds managed by the Adviser (the "RTW Funds"), and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser. |
| 2 | Common | Common Shares | 2022-09-07 | S | D | 1,557,346 | $8.71 | 4,315,102 | I See footnote | — | — | (F1) Ordinary course rebalancing transactions in which certain RTW Funds (as defined below) rebalance holdings of the Issuer among the RTW Funds. After the transactions reported herein, the amount of Common Shares of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change. (F2) This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to Common Shares held by certain investment funds managed by the Adviser (the "RTW Funds"), and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser. |